HomeStock ScreenerArchit OrganosysIntrinsic Value

Archit Organosys Intrinsic Value

Archit Organosys (ARCHITORG) median intrinsic value is ₹44.21 from 9 valuation models (range ₹22–₹53), vs current price ₹50.17 — -11.9% downside (Trading Above Median Value), margin of safety -13.5%. Browse Archit Organosys annual reports for revenue, profit, balance sheet and cash flow data.

Current Stock Price
₹50.17
Primary Intrinsic Value
₹41.76
Market Cap
₹105.4 Cr
-11.9% Downside
Median Value
₹44.21
Value Range
₹22 - ₹53
Assessment
Trading Above Median Value
Safety Margin
-13.5%

ARCHITORG Valuation Methods Summary — DCF, Graham Number & P/E

Archit Organosys intrinsic value across 9 models vs current price ₹50.17 — upside/downside and value range per method. For current market price and key ratios, visit Archit Organosys screener.

Method Type Intrinsic Value Range Upside/Downside Details
P/E Based Valuation earnings ₹41.76 ₹33.41 - ₹50.11 -16.8% EPS: ₹3.48, Sector P/E: 12x
Book Value Method asset ₹30.48 ₹27.43 - ₹33.53 -39.2% Book Value/Share: ₹30.48, P/B: 1.0x
Revenue Multiple Method revenue ₹53.33 ₹48.00 - ₹58.66 +6.3% Revenue/Share: ₹66.67, P/S: 0.8x
EBITDA Multiple Method earnings ₹45.71 ₹41.14 - ₹50.28 -8.9% EBITDA: ₹16.00Cr, EV/EBITDA: 6x
Simple DCF (5Y) dcf ₹44.21 ₹35.37 - ₹53.05 -11.9% CF Growth: 5.0%, Discount: 15%
PEG Ratio Method growth ₹22.27 ₹20.04 - ₹24.50 -55.6% EPS Growth: 8.0%, Fair P/E: 6.4x
Growth Adjusted P/E growth ₹28.68 ₹25.81 - ₹31.55 -42.8% Revenue Growth: 6.0%, Adj P/E: 8.2x
ROE Based Valuation profitability ₹45.71 ₹41.14 - ₹50.28 -8.9% ROE: 12.5%, P/E Multiple: 12x
Graham Defensive Method conservative ₹48.85 ₹43.97 - ₹53.74 -2.6% EPS: ₹3.48, BVPS: ₹30.48
Method Types: Earnings Asset DCF Growth Dividend Conservative

ARCHITORG Intrinsic Value vs Market Price — All Valuation Models

Archit Organosys fair value range ₹22–₹53 vs current market price ₹50.17 across 9 valuation models. Also explore Archit Organosys share price performance to track price trends across different timeframes.

ARCHITORG Intrinsic Value Analysis — Undervalued or Overvalued?

Archit Organosys median intrinsic value ₹44.21, current price ₹50.17 — Trading Above Median Value by 11.9%, margin of safety -13.5%.

What is the intrinsic value of ARCHITORG?

Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Archit Organosys (ARCHITORG) is ₹44.21 (median value). With the current market price of ₹50.17, this represents a -11.9% variance from our estimated fair value.

The valuation range spans from ₹22.27 to ₹53.33, indicating ₹22.27 - ₹53.33.

Is ARCHITORG undervalued or overvalued?

Based on our multi-method analysis, Archit Organosys (ARCHITORG) appears to be trading above median value by approximately 11.9%.

ARCHITORG Financial Health — Key Ratios vs Industry Benchmarks

Archit Organosys financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.

Financial Metric Current Value Industry Benchmark Assessment Impact on Valuation
Current Ratio 4.20 Industry Standard: 2.0+ Above 2.0 Measures short-term liquidity capacity
Return on Equity 12.5% Industry Standard: 15%+ Above 10% Measures shareholder return efficiency
Operating Margin -1.0% Industry Standard: 20%+ Below 10% Indicates operational efficiency level
Asset Turnover Ratio 1.30x Industry Standard: 1.0x+ Above 1.0x Measures asset utilization efficiency

ARCHITORG Cash Flow Quality — Operating & Free Cash Flow

Archit Organosys operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.

Period Operating Cash Flow Free Cash Flow Cash Flow Quality Sustainability Score
March 2024 ₹10 Cr ₹9 Cr Positive Free Cash Flow 8/10
March 2023 ₹17 Cr ₹12 Cr Positive Free Cash Flow 8/10